TNDM - TNDM DEADLINE TOMORROW: ROSEN LEADING INVESTOR COUNSEL Encourages Tandem Diabetes Care Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action – TNDM | Benzinga
NEW YORK, Nov. 06, 2023 (GLOBE NEWSWIRE) --
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) between August 3, 2022 and November 2, 2022, both dates inclusive (the "Class Period"), of the important November 7, 2023 lead plaintiff deadline.
SO WHAT: If you purchased Tandem securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Tandem class action, go to https://rosenlegal.com/submit-form/?case_id=19024 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 7, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate ...